In contrast, HF macrophages were characterized by upregulated Igfbp4 (insulin-like growth factor binding protein 4), a negative regulator of IGF1 signaling, proposed as a potential therapeutic strategy target for HF due to its cardiogenic properties [106]. Here, IGFBP4 is linked to hydrops fetalis.